Skip to content

SAD/MAD study with PTC844

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-501986-38-00
Acronym
PTC844-SMAD-101-HV
Enrollment
64
Registered
2022-12-23
Start date
2022-12-30
Completion date
2023-12-22
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auto immune disorders

Interventions

None listed

Sponsors

PTC Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026